BEACON PLN-74809-IPF-206. A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Pliant Therapeutics, Inc.
Start Date
January 19, 2024
End Date
August 31, 2028
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Pliant Therapeutics, Inc.
Start Date
January 19, 2024
End Date
August 31, 2028